000 | 03021cgm a2200565 a 4500 | ||
---|---|---|---|
001 | HST1046_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 201104s2020 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1046 _bHenry Stewart Talks |
035 | _a(UkLoHST)223 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aHerholz, Karl, _u(University of Manchester, UK) _4spk |
|
245 | 1 | 0 |
_aMolecular brain imaging (PET) in diseases with dementia _h[electronic resource] / _cKarl Herholz. |
260 |
_aLondon : _bHenry Stewart Talks, _c2020. |
||
300 |
_a1 online resource (1 streaming video file (22 min.) : _bcolor, sound). |
||
490 | 1 |
_aNeurodegenerative diseases : fundamentals, research methods, latest advances, _x2056-452X |
|
490 | 1 |
_aPeriodic reports : advances in clinical interventions and research platforms, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
500 | _aUpdated version of a talk first published in 2007 under the title: PET ligands and metabolic brain imaging. | ||
505 | 0 | _aContents: Brain imaging with positron emission tomography (PET) for dementia diagnosis and research -- Cerebral glucose metabolism in mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia & depression -- Imaging of pathological markers (beta-amyloid and tau) in Alzheimer's disease -- Imaging of neurotransmitters and receptors, in the dopaminergic and cholinergic system -- Multiple systems profiling in dementia, Parkinson's and related motor disorders. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aBrain _xRadionuclide imaging. |
|
650 | 0 |
_aDementia _xDiagnosis. |
|
650 | 0 |
_aNervous system _xDegeneration. |
|
650 | 0 |
_aNervous system _xDiagnostic imaging. |
|
650 | 0 | _aTomography, Emission. | |
650 | 2 |
_aAlzheimer Disease _xdiagnostic imaging. |
|
650 | 2 |
_aBrain _xdiagnostic imaging. |
|
650 | 2 | _aCholinergic Agents. | |
650 | 2 |
_aCognitive Dysfunction _xdiagnostic imaging. |
|
650 | 2 | _aDepression. | |
650 | 2 | _aDopamine. | |
650 | 2 |
_aFrontotemporal Dementia _xdiagnostic imaging. |
|
650 | 2 |
_aLewy Body Disease _xdiagnostic imaging. |
|
650 | 2 |
_aMotor Disorders _xdiagnostic imaging. |
|
650 | 2 |
_aNeurodegenerative Diseases _xdiagnostic imaging. |
|
650 | 2 | _aNeurotransmitter Agents. | |
650 | 2 |
_aParkinson Disease _xdiagnostic imaging. |
|
650 | 2 | _aPositron-Emission Tomography. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pNeurodegenerative diseases : fundamentals, research methods, latest advances. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPeriodic reports. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/223/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/4448/ _3Series (Periodic reports) |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/31/ _3Series (Neurodegenerative diseases) |
999 |
_c75899 _d75899 |